IEX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/14/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeIEX
Market Capitalization194.23 mln
Float96.47 mln
Earnings Date11/12/2026
Piotroski F-Score
3
/ 9
Below average
1-Year Forecast
7.39
Transformational upside
Relative Strength
98
/ 100
Top performer
Debt / Equity
0.00
Debt-free
ROE
-226
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Cardiol Therapeutics is a Canadian clinical-stage company founded in 2017 and based in Oakville, Ontario, focused on developing treatments for heart disease. Its main drug, CardiolRx, is currently being tested in a large international Phase III trial to assess how well it works and how safe it is for patients with acute myocarditis and recurring pericarditis. The company is also working on an injectable treatment called CRD-38, which is in early-stage research for heart failure.
